Royalty Pharma Plc (RPRX) stock chart and technical analysis

Indicator summary: Neutral (2 bullish, 2 bearish, 1 neutral). As of 2026-09-18, the close was $58.41: 1.3% below the 50-day average and 17.3% above the 200-day average, which is rising. RSI (14) is 42, in its neutral range. MACD is bearish after a cross in the last 10 days. The stock sits 80% of the way up its 52-week range of $33.97 to $64.38, on 2.4x its 20-day average volume.

Indicator	Reading	Read
50-day average	$59.19	Price 1.3% below
200-day average	$49.78	Price 17.3% above, average rising
50 vs 200-day	50 above 200	Golden-cross alignment
RSI (14)	42	Neutral range
MACD (12, 26, 9)	-0.23 vs +0.27	Bearish cross in the last 10 days
52-week range	$33.97 to $64.38	80% of the way up the range
Volume vs 20-day average	2.4x	Heavy

What followed this setup for RPRX

When it closed above its 200-day average (665 days), it was higher 63 trading days later 63% of the time, median +4.7%.
When it closed below its 50-day average (739 days), it was higher 63 trading days later 54% of the time, median +1.8%.
When it had MACD below its signal line (754 days), it was higher 63 trading days later 55% of the time, median +1.6%.
All days since 2020 (1,510 days): higher 63 trading days later 55% of the time, median +1.8%.

Base rates use RPRX's own daily history since 2020; they describe the past, not a forecast.

ŷRobot chart signal: Hold, from the chart signal model.

RPRX analysis: AI score, fair value and forecast · Is it a bull or a bear market today? · All covered stocks

ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.